HIV

Consolidation and drug costs will play a key role in the future of specialty pharmacy.

Strategic, operational, and legal hurdles must be conquered before implementing this contract.

A number of hurdles in HIV, including preventative efforts, still need to be addressed.

Achieving linkage to care and viral suppression among patients with HIV improves overall wellbeing and prevents new infections.

Screening for drug interactions is a challenge when a patient with HIV presents with several prescriptions.

We asked Jeffrey R. Aeschlimann, PharmD, an infectious disease specialist who is on the faculty of the University of Connecticut's Schools of Medicine and Pharmacy, to answer questions about drug interactions in patients with HIV.

Scientist map all mutations that help HIV evolve away from PGT151.

HIV clinical staff should ask questions about each patient’s relationships and sexual activity regularly and redundantly.

Walgreens and Greater Than AIDS, a leading national public information response to the domestic HIV/AIDS epidemic, are teaming up for the seventh straight year with health departments and local AIDS service organizations to offer free HIV testing and counseling about prevention strategies

Top articles of the week on Specialty Pharmacy Times.

Gel is 3 times more effective among women with Lactobacillus-dominate microbiome.

In 2015, 960,000 people were newly-infected with HIV in Eastern and Southern Africa.

HIV-positive women had higher rates of acquiring HPV and lower rates of clearing HIV infection.

Medications that suppress viral loads aid HIV-infected men who want children.

HIV/AIDS is the number 1 killer among women of reproductive age.

Men who have sex with men had the highest number of HIV diagnoses.

A look at last week's top stories in the world of pharmacy.

The drug is indicated as a combination treatment of HIV and for pre-exposure prophylaxis.

FDA approves first generic version of emtricitabine and tenofovir disoproxil fumarate (Truvada).

There are few shortcuts that address the large number of medications and different treatment regimens that are needed to treat patients with HIV.

Often, pharmacists look for shortcuts so they can remember complex information or update outdated learning, a technique that most pharmacists learn and refine while they are in pharmacy school. But when it comes to treatment of HIV, there are few shortcuts that address the large number of medications and different treatment regimens that are needed to treat patients.

Treatment de-escalation would reduce adverse events, treatment costs, and the need for virological monitoring.

The findings could lead to speed the development of an HIV vaccine.

Top news of the day from across the health care landscape.

The TZA test is faster, more cost-effective, and less labor-intensive than the current test for finding dormant HIV cells.

Gilead plans to file for approval of novel HIV drug in the United States and Europe this year.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses trends in specialty drug cost management.

HIV-positive individuals are twice as likely to die of smoking than the disease.

Patients with HIV can now expect to live into old age, and therefore need links to the community health network.

Many community pharmacists wonder what they can and should do for their patients who have HIV.